Ardea Biosciences Announces Positive Top-Line Results from Phase 2b ... - PR Newswire (press release)

Ardea Biosciences Announces Positive Top-Line Results from Phase 2b ... PR Newswire (press release) This was a 28-day, randomized, double-blind, placebo-controlled, study conducted in 208 gout patients with elevated uric acid levels (sUA greater than or ... and more »

Ardea's Phase II gout drug shows promise - FierceBiotech

Ardea's Phase II gout drug shows promise FierceBiotech Only 30 percent to 40 percent of gout patients respond adequately to allopurinol alone. The only serious adverse event in the study, a fatal myocardial ... ARDEA BIOSCIENCES GARNERS POSITIVE RESULTS IN GOUT CANDIDATE TRIAL; SHARES ON ...Zacks.com Ardea Biosciences Announces Positive Top-Line Results from Phase 2b ...FierceBiotech all 24 news articles »

Savient's gout drug sees manufacturing hiccups - Reuters

Savient's gout drug sees manufacturing hiccups Reuters Summer Street Research analyst Carol Werther, however, said she was concerned about how long it would take to fix the issue, especially since it was unclear ... Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) Hits New 52-Week Low at .30American Banking News all 35 news articles »

New research reveals more on age-old bouts of gout - Monsters and Critics.com

New research reveals more on age-old bouts of gout Monsters and Critics.com Recent scientific research has shed more light on the molecular processes that cause this joint disorder. 'Gout is a good example of how new findings on a ... and more »